View Sarah Denham's ProfileAs a senior leader within the pharmaceutical industry, Sarah Denham is passionate about fostering effective joint working between the NHS and pharmaceutical and medtech companies to deliver the best possible outcomes for patients. This is achieved through innovative, well-designed services and care pathways that address health inequalities while optimising NHS resources. Sarah has a particular interest and extensive knowledge of cardiovascular disease, diabetes, respiratory diseases, and oncology, with a focus on breast and ovarian cancers.
With 14 years of experience in the pharmaceutical industry, Sarah has an in-depth understanding of the NHS and scientific research and how they translate into national public and clinical policy. Her strong knowledge of NHS policy and commissioning structures enables her to provide strategic counsel, helping clients successfully engage with NHS stakeholders through meaningful conversations. She encourages clients to think differently and consider the entire patient journey, ensuring that products align effectively with NHS integrated care pathways.
Sarah is highly experienced in developing strategic brand plans and leading partnership initiatives between patient groups, academic institutions, professional bodies, and the NHS to enhance primary, secondary, and tertiary care services. Her expertise includes leading cross-functional teams to capitalise on opportunities arising from government initiatives such as the Accelerated Access Collaborative, driving healthcare innovation, and delivering service redesign projects that have been recognised by NICE as examples of good practice.
Previous Masterclasses
